The Business Times
SUBSCRIBERS

Corporate digest

google-preferred-sourceAdd BT as a preferred source
Published Tue, Jul 7, 2015 · 09:50 PM

Cordlife Group

CORDLIFE Group said on Tuesday that it has rejected an unsolicited third party offer for its shares in China Cord Blood Corporation and convertible notes due 2017. Instead, it will proceed with an earlier plan to sell them to Hang Seng-listed healthcare company Golden Meditech.

Digiland International

cordlife

Copyright SPH Media. All rights reserved.

Reuse this contentFeedback
Latest T-bills Treasury Bills Results & Interest NewsLatest SSB Singapore Savings Bonds NewsLatest COE Certificate of Entitlement News
Latest Johor-Singapore SEZ NewsLatest BTO Build To Order & Sales of Balance NewsLatest STI Straits Times Index NewsLatest SGX Dividends, Share Price NewsLatest Bonds Market NewsLatest Singapore Stocks To Buy NewsLatest Singapore Economy News
View More